CNS effects of sumatriptan and rizatriptan in healthy female volunteers.

Where do triptans act in the treatment of migraine? Pain (2005) 0.96

Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain (2009) 0.88

Headaches related to triptans therapy in patients of migrainous vertigo. J Headache Pain (2008) 0.82

A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. Int J Med Sci (2009) 0.79

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. Br J Clin Pharmacol (2011) 0.76

CNS effects of sumatriptan and rizatriptan. Cephalalgia (2004) 0.76

Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas. J Neurophysiol (2015) 0.75

Dizziness produced by a potent 5HT(1A) receptor agonist (eptapirone) is not due to postural hypotension. Psychopharmacology (Berl) (2004) 0.75

Molecular cloning of the a1 locus of Zea mays using the transposable elements En and Mu1. EMBO J (1985) 6.97

Establishing risk of human experimentation with drugs: lessons from TGN1412. Lancet (2006) 6.55

pBINPLUS: an improved plant transformation vector based on pBIN19. Transgenic Res (1995) 3.79

The kinesin-like protein KLP61F is essential for mitosis in Drosophila. J Cell Biol (1993) 3.32

Serious intercurrent disease in healthy volunteers in clinical pharmacological research. Lancet (1992) 3.21

Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13

The Arabidopsis MALE STERILITY 2 protein shares similarity with reductases in elongation/condensation complexes. Plant J (1997) 2.80

Molecular characterization of the CER1 gene of arabidopsis involved in epicuticular wax biosynthesis and pollen fertility. Plant Cell (1995) 2.79

Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A (1999) 2.70

The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system. J Psychopharmacol (2004) 2.68

Function search in a large transcription factor gene family in Arabidopsis: assessing the potential of reverse genetics to identify insertional mutations in R2R3 MYB genes. Plant Cell (1999) 2.23

Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers. Circulation (1992) 2.10

Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res (2013) 2.01

Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Thromb Haemost (1991) 1.94

ANTHOCYANINLESS2, a homeobox gene affecting anthocyanin distribution and root development in Arabidopsis. Plant Cell (1999) 1.84

Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang (2008) 1.82

A two-component enhancer-inhibitor transposon mutagenesis system for functional analysis of the Arabidopsis genome. Plant Cell (1999) 1.76

[Prions and blood donation]. Med Clin (Barc) (2001) 1.72

Re-engineering the European Union Clinical Trials Directive. Lancet (2012) 1.71

Transposon tagging of a male sterility gene in Arabidopsis. Nature (1993) 1.68

Pleural effusion in multiple myeloma. Chest (1994) 1.61

Estimating impossible curves using NONMEM. Br J Clin Pharmacol (1996) 1.59

Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant. Clin Pharmacol Ther (2010) 1.57

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology (Berl) (2008) 1.55

Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens (2004) 1.51

Variability of splanchnic blood flow measurements using MR velocity mapping under fasting and post-prandial conditions--comparison with echo-Doppler. J Hepatol (1997) 1.50

Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45

Recognition models of alphanumeric characters. Percept Psychophys (1981) 1.45

Pulse wave velocity and coronary risk stratification. Rev Port Cardiol (2009) 1.44

Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol (1984) 1.42

Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther (1992) 1.41

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41

[New drugs; exenatide and sitagliptin]. Ned Tijdschr Geneeskd (2008) 1.40

[New drugs; rimonabant]. Ned Tijdschr Geneeskd (2007) 1.39

Longitudinal left ventricular function in a population of healthy adults: a tissue Doppler imaging study. Rev Port Cardiol (2001) 1.38

A two-element Enhancer-Inhibitor transposon system in Arabidopsis thaliana. Mol Gen Genet (1995) 1.37

[New drugs; sunitinib and sorafenib]. Ned Tijdschr Geneeskd (2007) 1.37

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci (2009) 1.36

Cell lineage-specific expression of modulo, a dose-dependent modifier of variegation in Drosophila. EMBO J (1992) 1.28

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol (2001) 1.25

Effect of intrapulmonary tetrahydrocannabinol administration in humans. J Psychopharmacol (2008) 1.25

Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol (1991) 1.25

A genetic map of potato (Solanum tuberosum) integrating molecular markers, including transposons, and classical markers. Theor Appl Genet (1995) 1.25

Genetic diversity measures of local European beef cattle breeds for conservation purposes. Genet Sel Evol (2001) 1.24

OryGenesDB: a database for rice reverse genetics. Nucleic Acids Res (2006) 1.22

A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron. J Pharmacokinet Biopharm (1999) 1.22

Identification of R-gene homologous DNA fragments genetically linked to disease resistance loci in Arabidopsis thaliana. Mol Plant Microbe Interact (1998) 1.20

Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther (2000) 1.20

Can we improve gait skills in chronic hemiplegics? A randomised control trial with gait trainer. Eura Medicophys (2007) 1.19

Kisspeptin neurons in the ovine arcuate nucleus and preoptic area are involved in the preovulatory luteinizing hormone surge. Endocrinology (2009) 1.18

Clinical pharmacology: a declaration of intent. Br J Clin Pharmacol (2010) 1.18

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin Pharmacol Ther (1991) 1.16

Purification and characterization of an extracellular protease from Xenorhabdus nematophila involved in insect immunosuppression. Appl Environ Microbiol (2002) 1.16

A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol Psychiatry (2008) 1.14

Kisspeptin is present in ovine hypophysial portal blood but does not increase during the preovulatory luteinizing hormone surge: evidence that gonadotropes are not direct targets of kisspeptin in vivo. Endocrinology (2007) 1.14

A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers. Clin Pharmacol Ther (1991) 1.14

REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers. J Psychopharmacol (2003) 1.13

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br J Clin Pharmacol (2005) 1.12

Pictorial review of the many faces of bronchioloalveolar cell carcinoma. Br J Radiol (2007) 1.12

High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol (1999) 1.12

Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl) (2001) 1.11

Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res (2001) 1.11

Early and multiple Ac transpositions in rice suitable for efficient insertional mutagenesis. Plant Mol Biol (2001) 1.10

Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia (1999) 1.10

Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol (1997) 1.09

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol (2006) 1.09

Biomarkers for the effects of benzodiazepines in healthy volunteers. Br J Clin Pharmacol (2003) 1.08

Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model. Clin Pharmacol Ther (1984) 1.08

Good clinical practice: a question of balance. Br J Clin Pharmacol (1993) 1.08

Nanofabrication with pulsed lasers. Nanoscale Res Lett (2010) 1.07

The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br J Clin Pharmacol (2005) 1.06

The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects. Clin Pharmacol Ther (1985) 1.06

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol (1985) 1.06

Colocalization of kisspeptin and gonadotropin-releasing hormone in the ovine brain. Endocrinology (2005) 1.05

MDMA study. Neuropsychopharmacology (1999) 1.05

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J Psychopharmacol (1999) 1.05

Diel variation of the RNA/DNA ratios in Crassostrea angulata (Lamarck) and Ruditapes decussatus (Linnaeus 1758) (Mollusca: Bivalvia). J Exp Mar Bio Ecol (2001) 1.05

Mechanisms of action and medicinal applications of abscisic Acid. Curr Med Chem (2010) 1.03

Leukemia risk models in primary myelofibrosis: an International Working Group study. Leukemia (2012) 1.01

Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol (1998) 1.01

Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid (2001) 1.01

Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan. Pharm Res (2001) 1.00